Results 121 to 130 of about 14,200 (285)

Nephrotic syndrome after treatment of Crohn′s disease with mesalamine: Case report and literature review

Avicenna Journal of Medicine, 2012
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recently, case reports have been published documenting the development of nephrotic syndrome after the treatment for inflammatory bowel disease with 5 ...
Belal M Firwana, Rim Hasan, Walid Chalhoub, Mazen Ferwana, Jin-Yong Kang, Joshua Aron, Joseph Lieber   +6 more
doaj   +1 more source

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn’s disease

Clinical and Experimental Gastroenterology, 2009
Glen A Doherty, Mark A PeppercornCenter for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA, USAAbstract: 5-aminosalicyclates (5-ASA) remain a key first-line therapy for patients with ulcerative ...
Glen A Doherty, Mark A Peppercorn
doaj  

Simple one-pot green method for large-scale production of mesalamine, an anti-inflammatory agent

Green Processing and Synthesis, 2019
We report a rapid and efficient synthesis protocol for mesalamine via a green approach with 2-chloro-5-nitrobenzoic acid as the starting material, for its large-scale production.
Vijaya Lakshmi C., Katari Naresh Kumar, Jonnalagadda Sreekantha B.   +2 more
doaj   +1 more source

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission [PDF]

, 2015
Gary R. Lichtenstein, Glenn L. Gordon, Salam Zakko, Uma K. Murthy, Shahriar Sedghi, Ron E. Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes   +9 more
openalex   +1 more source

Mesalamine-induced photosensitivity – A case report and literature review

, 2023
Svetlana Popadić, Igor Kapetanović, Aleksandra Sokic‐Milutinovic   +2 more
openalex   +1 more source

Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.

Clinical Gastroenterology and Hepatology, 2023
Vivek C. Goodoory, A. Tuteja, C. Black, A. Ford   +3 more
semanticscholar   +1 more source

Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

Drug Design, Development and Therapy, 2014
David Pierce,1 Mary Corcoran,2 Patrick Martin,2 Karen Barrett,1 Susi Inglis,1 Peter Preston,2 Thomas N Thompson,3 Sandra K Willsie3 1Shire, Basingstoke, UK; 2Shire, Wayne, PA, USA; 3PRA International, Lenexa, KS, USA Background: MMX® mesalamine is a
Pierce D, Corcoran M, Martin P, Barrett K, Inglis S, Preston P, Thompson TN, Willsie SK   +7 more
doaj  

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease

JGH Open, 2019
Background and Aim The literature on medication adherence in patients with inflammatory bowel disease (IBD) is heterogeneous. The present study aimed to identify the rates and predictors of nonadherence to medications in IBD. Methods This cross‐sectional
Sanjeevani K Tomar, Saurabh Kedia, Namrata Singh, Ashish D Upadhyay, Nagesh Kamat, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Myopericarditis in a patient with ulcerative colitis treated with mesalamine—Case report and review of the literature [PDF]

, 2014
Marta Roczek, Łukasz Polak, Marzenna Zielińska, Krzysztof Chiżyński   +3 more
openalex   +1 more source

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis [PDF]

, 2008
Michael A. Kamm, Gary R. Lichtenstein, William J. Sandborn, Stefan Schreiber, Kirstin Lees, Karen Barrett, Raymond E. Joseph   +6 more
openalex   +1 more source